NCT01554046View on ClinicalTrials.gov

The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD)

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Attention Deficit/Hyperactivity Disorder Combined TypeADHD Predominantly Inattentive TypeADHD Predominantly Hyperactivity TypeADHD-not Other Specified
Interventions
DRUG

Methylphenidate- Ritalin IR (Immediate Release)

"Duration of treatment- 4 weeks. Dosage- up to 3 times/day.~* Ages 6-12, up to 25Kg - 35mg maximum per day.~* Ages 6-12, above 25Kg - 50mg maximum per day.~* Ages 12-65, above 25Kg - 80mg maximum per day."

Trial Locations (1)

Unknown

ADHD Medical Clinic, Child and Adolescent Psychiatry Unit, Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT01554046 - The Effect of Methylphenidate Treatment in Familial Attention Deficit/Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter